top of page

Patrick Basanez

Director
GBX GROUP

A well accomplished professional with over 15 years industry experience.

Patrick has an established record of creating, managing and executing winning business strategies. His unique flare enables him to connect with every aspect of business and he is able provide a systemic tactical plan of action understood by all.

Alongside his dedicated team of professionals, Patrick produces bespoke projects and elite level events in the pharmaceutical and manufacturing markets. His hands-on training approach motivates and inspires his team. This approach allows a guided collaborative working relationship, proving that hard-work and dedication equals successful results.

Patricks role encompasses the entire spectrum of corporate planning and business development - including but not limited to strategic direction, market research, value added services, commercialisation and sales profitability.

https://www.linkedin.com/in/patrickbasanez/

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
MEETINGS
MEMBERS
Speakers
Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jens H. Vogel

SVP & Head of Global Biologics Operating Unit, Merck & Co

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Nuno Fontes

SVP, Head of Global CMC at WuXi Biologics

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Behzad Mahdavi

CEO and Board Member of InnoGI Technologies

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Uwe Gottschalk

Operating Partner at Keensight Capital - Former CSO of Lonza

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Dr Judy Chou

President and CEO of AltruBio

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jesse McCool

CSO of Bionova Scientific - Former Co-Founder & CEO of Wheeler Bio

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Angela Vollstedt

Global Director, Cell & Gene Therapies Portfolio Management at Novartis

bottom of page